Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-057292
Filing Date
2024-05-10
Accepted
2024-05-09 17:40:01
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vera-20240331.htm   iXBRL 10-Q 1969978
2 EX-10.2 vera-ex10_2.htm EX-10.2 229485
3 EX-10.3 vera-ex10_3.htm EX-10.3 220811
4 EX-31.1 vera-ex31_1.htm EX-31.1 15134
5 EX-31.2 vera-ex31_2.htm EX-31.2 15103
6 EX-32.1 vera-ex32_1.htm EX-32.1 9082
7 EX-32.2 vera-ex32_2.htm EX-32.2 9284
8 GRAPHIC img130372807_0.jpg GRAPHIC 6701
9 GRAPHIC img130372807_1.jpg GRAPHIC 6701
10 GRAPHIC img130372807_2.jpg GRAPHIC 863
11 GRAPHIC img130372807_3.jpg GRAPHIC 6701
12 GRAPHIC img131296328_0.jpg GRAPHIC 6701
13 GRAPHIC img131296328_1.jpg GRAPHIC 6701
14 GRAPHIC img131296328_2.jpg GRAPHIC 863
15 GRAPHIC img131296328_3.jpg GRAPHIC 6701
  Complete submission text file 0000950170-24-057292.txt   7919863

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vera-20240331.xsd EX-101.SCH 1023228
79 EXTRACTED XBRL INSTANCE DOCUMENT vera-20240331_htm.xml XML 1173411
Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Filer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40407 | Film No.: 24932141
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)